Financials

People

Activity

date founded

General

About Company
Exacis is a development-stage immuno-oncology company focused on curing cancer by harnessing the human immune system.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Exacis

founded date

01.01.2020

Number of employees

IPO status

Private

Description

Exacis creates induced pluripotent stem cells (iPSC) using mRNA-based cell reprogramming and gene editing technologies to engineer NK and T cells that resist immune rejection and target tumors. The company's cellular therapeutics aim to democratize access to safe and effective treatments for solid tumors and hematologic malignancies, and they are developing next-generation therapies using proprietary mRNA-based technologies to engineer potent and targeted NK and T cells.
Contacts

Contact Email

Social url

Similar Companies
1000
NAKI Therapeutics

NAKI Therapeutics

NAKI Therapeutics develops immunotherapy to safely kill cancer cells using natural killer cells.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Summit, NJ, USA

total rounds

1
Fate Therapeutics

Fate Therapeutics

Fate Therapeutics develops stem cell therapeutics using biological mechanisms that guide cell fate.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Biopharma, Health Care

Location

La Jolla, San Diego, CA, USA

total rounds

14

total raised

$1.23B
Angiocrine Bioscience

Angiocrine Bioscience

Angiocrine Bioscience has developed a cellular platform to amplify stem and progenitor cells in both human and mouse models.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

total rounds

3

total raised

$77.12M
Lyell Immunopharma

Lyell Immunopharma

Lyell Immunopharma is developing cellular therapies to cure cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Software, Health Care

Location

South San Francisco, CA, USA

total rounds

2

total raised

$493M

count Of Investments

6

Financials

Co-Investors

People

Founders
3

Matthew Angel

organization founded

1

Matthew Angel

Gregory Fiore
Gregory Fiore

Gregory Fiore

Dr. Fiore is a Co-Founder and is the President and Chief Executive Officer of Sollis Therapeutics. He previously founded two successful healthcare consultancies, Fiore Healthcare Advisors and SSI Strategy. He has served as the Chief Medical Officer at The Medicines Company and Synspira. Dr. Fiore also held senior positions at Merck, Abbott Laboratories, and McKinsey Consulting. Dr. Fiore was class valedictorian at New York Medical College and trained in Internal Medicine, Pulmonary and Critical Care Medicine at Harvard Medical School.

current job

Exacis Biotherapeutics
Exacis Biotherapeutics

organization founded

4

Gregory Fiore

James Pan

James Pan is the Co-Founder and Chief Business Officer of Exacis Biotherapeutics.

current job

Exacis Biotherapeutics
Exacis Biotherapeutics

organization founded

1

James Pan

Employee Profiles
4
Dirk Huebner

Dirk Huebner

Chief Medical Officer

Matt Angel

Matt Angel

Co-Founder and Scientific Advisory Board Chair

Gregory Fiore

Gregory Fiore

Chief Executive Officer

James Pan

Co-Founder & Chief Business Officer

Activity

Recent News
0